Literature DB >> 7649393

Mutations in the Caenorhabditis elegans gene vab-3 reveal distinct roles in fate specification and unequal cytokinesis in an asymmetric cell division.

H M Chamberlin1, P W Sternberg.   

Abstract

Asymmetric cell divisions in which a precursor cell distributes fate potential unequally between the two daughter cells represent one of the major mechanisms for fate specification during development. Such mechanisms suggest at least two distinct cellular activities: factors that act to establish asymmetry in the precursor cell and factors that are distributed or activated unequally and function to make the daughter cells different from each other. In Caenorhabditis elegans, cytokinesis of the first division of the male-specific postembryonic blast cell B is unequal, and the two daughters adopt different fates. Others have observed that the genes lin-17 and lin-44 are required, respectively, to establish and to orient this asymmetric division. Mutations in lin-17 and lin-44 coordinately disrupt cytokinesis and fate specification. We describe the function of the gene vab-3 in the B cell lineage. Mutations in vab-3 disrupt the fate of the anterior daughter of B, B.a. However, unlike lin-17 and lin-44, mutations in vab-3 can disrupt fate without the corresponding disruption of unequal cytokinesis. Analysis of lin-17;vab-3 double mutants suggests that vab-3 acts after lin-17 for B.a. fate specification. Double mutant analysis has also identified additional functions of lin-17 in the B lineage subsequent to this first division.

Entities:  

Mesh:

Year:  1995        PMID: 7649393     DOI: 10.1006/dbio.1995.1246

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  9 in total

Review 1.  The development of sexual dimorphism: studies of the Caenorhabditis elegans male.

Authors:  Scott W Emmons
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-05-13       Impact factor: 5.814

2.  An HMG1-like protein facilitates Wnt signaling in Caenorhabditis elegans.

Authors:  L I Jiang; P W Sternberg
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

3.  Polyomavirus small t antigen prevents retinoic acid-induced retinoblastoma protein hypophosphorylation and redirects retinoic acid-induced G0 arrest and differentiation to apoptosis.

Authors:  A Yen; L Placanica; S Bloom; S Varvayanis
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  Genetic analysis of the Caenorhabditis elegans pax-6 locus: roles of paired domain-containing and nonpaired domain-containing isoforms.

Authors:  Hediye Nese Cinar; Andrew D Chisholm
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

5.  The Paired-box protein PAX-3 regulates the choice between lateral and ventral epidermal cell fates in C. elegans.

Authors:  Kenneth W Thompson; Pradeep Joshi; Jessica S Dymond; Lakshmi Gorrepati; Harold E Smith; Michael W Krause; David M Eisenmann
Journal:  Dev Biol       Date:  2016-03-04       Impact factor: 3.582

6.  Re-programming of C. elegans male epidermal precursor fates by Wnt, Hox, and LIN-12/Notch activities.

Authors:  Hui Yu; Adeline Seah; Paul W Sternberg
Journal:  Dev Biol       Date:  2010-05-15       Impact factor: 3.582

7.  Sex chromosome evolution in parasitic nematodes of humans.

Authors:  Jeremy M Foster; Alexandra Grote; John Mattick; Alan Tracey; Yu-Chih Tsai; Matthew Chung; James A Cotton; Tyson A Clark; Adam Geber; Nancy Holroyd; Jonas Korlach; Yichao Li; Silvia Libro; Sara Lustigman; Michelle L Michalski; Michael Paulini; Matthew B Rogers; Laura Teigen; Alan Twaddle; Lonnie Welch; Matthew Berriman; Julie C Dunning Hotopp; Elodie Ghedin
Journal:  Nat Commun       Date:  2020-04-23       Impact factor: 14.919

8.  CEPsh glia development is not required for general AWC identity or AWC asymmetry.

Authors:  Rui Xiong; Yi-Wen Hsieh; Chiou-Fen Chuang
Journal:  MicroPubl Biol       Date:  2022-09-15

9.  Dicyema Pax6 and Zic: tool-kit genes in a highly simplified bilaterian.

Authors:  Jun Aruga; Yuri S Odaka; Akiko Kamiya; Hidetaka Furuya
Journal:  BMC Evol Biol       Date:  2007-10-25       Impact factor: 3.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.